STOCK TITAN

Meta product chief sells 20,000 shares

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Meta Platforms, Inc. (META) reported that Chief Product Officer Christopher K. Cox, through The Christopher K. Cox Revocable Trust, sold a total of 20,000 shares of Class A Common Stock on September 9, 2026 in open-market transactions under a Rule 10b5-1 trading plan.

The trust sold 18,578 shares at a weighted-average price of $650.21 per share (with individual trades between $650.00 and $650.93) and 1,422 shares at a weighted-average price of $651.15 (with trades between $651.015 and $651.26). A separate entry reports 55,046 shares of Class A Common Stock held indirectly by the Cox-Vadakan Irrevocable Remainder Trust.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Cox Christopher K
Role Chief Product Officer
Sold 20,000 shs ($13.01M)
Type Security Shares Price Value
Sale Class A Common Stock F1, F2, F3 18,578 $650.2121 $12.08M
Sale Class A Common Stock F1, F4, F3 1,422 $651.1496 $926K
holding Class A Common Stock F5 -- -- --
Holdings After Transaction: Class A Common Stock — 244,516 shares (Indirect, Christopher K. Cox Revocable Trust); Class A Common Stock — 55,046 shares (Indirect, Cox-Vadakan Irrevocable Remainder Trust)
Footnotes (5)
  1. F1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
  2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $650.00 to $650.93 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.
  4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $651.015 to $651.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.
Shares sold (total) 20,000 shares Class A Common Stock sold indirectly on September 9, 2026
First sale size 18,578 shares Sold by The Christopher K. Cox Revocable Trust on September 9, 2026
First sale weighted-average price $650.21 per share With prices ranging from $650.00 to $650.93
Second sale size 1,422 shares Sold by The Christopher K. Cox Revocable Trust on September 9, 2026
Second sale weighted-average price $651.15 per share With prices ranging from $651.015 to $651.26
Shares held by Cox-Vadakan Irrevocable Remainder Trust 55,046 shares Indirect holding of Class A Common Stock reported in the Form 4
Rule 10b5-1 plan adoption date May 19, 2026 Trading plan under which the reported sales were effected
Rule 10b5-1 trading plan regulatory
"sales reported were effected pursuant to the Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Revocable Trust financial
"Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust."
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
Irrevocable Remainder Trust financial
"Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did META executive Christopher K. Cox report in this Form 4?

He reported that a revocable trust associated with him sold 20,000 shares of Meta Platforms Class A Common Stock on September 9, 2026 in open-market transactions under a Rule 10b5-1 trading plan.

At what prices were the META shares sold in this Form 4?

The trust sold 18,578 shares at a weighted-average price of $650.21 per share, with trades from $650.00 to $650.93, and 1,422 shares at a weighted-average price of $651.15, with trades from $651.015 to $651.26.

Were the META share sales by Christopher K. Cox pre-planned?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Christopher K. Cox on May 19, 2026, indicating the trades followed a pre-established plan.

How many META shares were sold in total according to this Form 4?

The Form 4 reports that the revocable trust sold a total of 20,000 shares of Meta Platforms Class A Common Stock on September 9, 2026 across two weighted-average price transactions.

What indirect META share holdings are reported for Christopher K. Cox?

The filing reports 55,046 shares of Class A Common Stock held of record by the Cox-Vadakan Irrevocable Remainder Trust, for which Christopher K. Cox and Visra Vichit-Vadakan serve as co-trustees.

Are the META sales attributed directly to Christopher K. Cox personally?

The sales are attributed to shares held of record by The Christopher K. Cox Revocable Trust, where he is trustee. The Form 4 reports the transactions as indirect ownership rather than direct personal holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cox Christopher K

(Last)(First)(Middle)
C/O META PLATFORMS, INC.
1 META WAY

(Street)
MENLO PARK CALIFORNIA 94025

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Meta Platforms, Inc. [ META ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Product Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/09/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock09/09/2026S(1)18,578D$650.2121(2)245,938IChristopher K. Cox Revocable Trust(3)
Class A Common Stock09/09/2026S(1)1,422D$651.1496(4)244,516IChristopher K. Cox Revocable Trust(3)
Class A Common Stock55,046ICox-Vadakan Irrevocable Remainder Trust(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported were effected pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2026.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $650.00 to $650.93 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Shares held of record by Christopher K. Cox, Trustee of The Christopher K. Cox Revocable Trust.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $651.015 to $651.26 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. Shares held of record by Christopher K. Cox and Visra Vichit-Vadakan, Co-Trustees of The Cox-Vadakan Irrevocable Remainder Trust.
/s/ Erin Guldiken, attorney-in-fact for Christopher K. Cox09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading